Sorafenib in Combination With Carboplatin and Paclitaxel in Treating Participants With Metastatic or Recurrent Head and Neck Squamous Cell Cancer
about
Sorafenib in Combination With Carboplatin and Paclitaxel in Treating Participants With Metastatic or Recurrent Head and Neck Squamous Cell Cancer
description
clinical trial
@en
klinisch onderzoek
@nl
name
Sorafenib in Combination With ...... and Neck Squamous Cell Cancer
@en
type
label
Sorafenib in Combination With ...... and Neck Squamous Cell Cancer
@en
prefLabel
Sorafenib in Combination With ...... and Neck Squamous Cell Cancer
@en
P4844
P1050
P1476
A Phase II Study of Sorafenib ...... and Neck Squamous Cell Cancer
@en
P3098
NCT00494182
P580
2007-04-25T00:00:00Z
P582
2019-04-30T00:00:00Z